Quantification of the Benefit of Earlier Thrombolytic Therapy: Five-Year Results of the Grampian Region Early Anistreplase Trial (GREAT)

This publication has 25 references indexed in Scilit:

• Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT)
  BMJ, 1996
• Delay between the onset of symptoms of acute myocardial infarction and seeking medical assistance is influenced by left ventricular function at presentation.
  Heart, 1995
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Having of mortality at 1 year by domiciliary thrombolysis in the grampian region early anistreplase trial (GREAT)
  Journal of the American College of Cardiology, 1994
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.
  BMJ, 1992
• Components of delay time in suspected acute myocardial infarction with particular emphasis on patient delay
  Journal of Internal Medicine, 1990
• The prehospital phase of acute myocardial infarction in the era of thrombolysis
  The American Journal of Cardiology, 1990
• Early versus late hospital arrival for acute myocardial infarction in the western Washington thrombolytic therapy trials
  The American Journal of Cardiology, 1989
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988